Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 10, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-17
DOI
10.1038/s41419-018-0960-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BH3-only protein BIM: An emerging target in chemotherapy
- (2017) Shatrunajay Shukla et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma
- (2017) Yong-sheng Tu et al. NEOPLASIA
- Idelalisib in the management of lymphoma
- (2016) C. Y. Cheah et al. BLOOD
- Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
- (2016) B. L. Lampson et al. BLOOD
- Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells
- (2016) Yali Chen et al. ONCOLOGY REPORTS
- Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
- (2016) Jacqueline C. Barrientos OncoTargets and Therapy
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Idelalisib-associated Colitis
- (2015) Anna-Sophie Weidner et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine
- (2015) YAN LI et al. ONCOLOGY REPORTS
- Regulation of Bim in Health and Disease
- (2015) Ronit Vogt Sionov et al. Oncotarget
- Pro-apoptotic BIM is an essential initiator of physiological endothelial cell death independent of regulation by FOXO3
- (2014) M N Koenig et al. CELL DEATH AND DIFFERENTIATION
- Current and Future Challenges in the Surgical Treatment of Hepatocellular Carcinoma: A Review
- (2014) Georgios Tsoulfas et al. INTERNATIONAL SURGERY
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
- (2014) Ali Raza WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes
- (2012) Shannon M. Ruppert et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia
- (2012) L-N Zhang et al. CANCER GENE THERAPY
- Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis
- (2012) L. Ouyang et al. CELL PROLIFERATION
- Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway
- (2008) W Zhang et al. LEUKEMIA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started